<DOC>
	<DOCNO>NCT01604161</DOCNO>
	<brief_summary>This study conduct Japan . The aim study collect information efficacy safety Norditropin® ( somatropin ) long-term treatment short stature GHD ( Growth Hormone Deficiency ) epiphysial disc close short stature Turner Syndrome epiphysial disc close .</brief_summary>
	<brief_title>Non-interventional Study Patients Using Norditropin® Growth Hormone Deficiency Turner Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Growth hormone deficiency short stature due Turner Syndrome epiphyseal disc close Diabetic Patients malignant tumor Women either pregnant likely pregnant Known suspect allergy study product ( ) relate product</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>